期刊文献+

阿司匹林对卡托普利治疗充血性心力衰竭的影响

Influence of aspirin on the efficacy of captopril in the treatment of chronic congestive heart failure
下载PDF
导出
摘要 目的 :观察阿司匹林对卡托普利治疗充血性心力衰竭的影响。方法 :将 74例CHF患者按入院前是否服用阿司匹林分为 2组 ,均给予卡托普利12 .5mg口服 ,tid ,并逐渐加量为 2 5mg ,tid ,连服2 8d。结果 :未用阿司匹林组显效率为 4 6 .7% ,总有效率为 70 % ,与曾用阿司匹林组相比差异显著 (P <0 .0 5 ) ;患者心率明显下降 ,优于曾用阿司匹林组 (P<0 .0 5 ) ;心脏收缩功能参数LVEF、FS以及舒张功能参数E/A明显增加 (P <0 .0 1) ,且较曾用阿司匹林组为优 (P <0 .0 5 )。结论 :曾经应用阿司匹林的时间越长 ,卡托普利治疗CHF的效果越差。 AIM: To investigate the influence of aspirin on the efficacy of captopril in the treatment of chronic congestive heart failure (CHF). METHODS: 74 cases of CHF were divided into 2 groups depending on whether aspirin was administrated before captopril was given, then all patients were given captopril 12.5 - 25 mg , tid, for 28 days. RESULTS: In aspirin group, marked effective rate was 46.7 %, and total effective rate was 70%, superior to that in no aspirin group (P< 0.05 ). The heart rate (HR) evidently decreased (P< 0.05 ) in aspirin group. Other indices, including the left ventricular ejection fraction (LVEF),fraction shortening (FS) and the rate of filling velocity in early diastole over that in late diastole (E/A), were significantly increased (P< 0.01 ) in aspirin group. CONCLUSION: The longer is the administration of aspirin, the poorer is the effects of captopril added in the treatment of CHF.
作者 童延清
机构地区 广州中医药大学
出处 《中国临床药理学与治疗学》 CAS CSCD 2002年第5期440-442,共3页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 阿司匹林 卡托普利 充血性心力衰竭 心脏收缩功能 心脏舒张功能 CHF 疗效 aspirin captopril chronic congestive heart failure
  • 相关文献

参考文献7

  • 1Parmley WW. Pathophysiology of congestive heart failure[J]. Am J Cardiol, 1985;56:7A-11A
  • 2Kjekshus J, Swedberg K, Snapinn S. For the cooperative new scandinavian enalpril surviva study(consensus) trial group. Effects of enalapril on long-term mortality in severe congestive heart failure[J]. Am J Cardiol, 1992;69:103-7
  • 3Jull-Moller S, Jahnmatz B, Rosen A, et al. For the swedish angina pectoris aspirin trial(sapat) group. Double-blinded trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angin apectoris[J]. Lancet, 1992;340:1421-5
  • 4Cleland JG, Bulpitt CJ, Falk RH, et al. Is aspirin safe for patients with heart failure[J]? Br Heart J, 1995;74:215-9
  • 5Dzau VJ, Packer M, Lilly LS, et al. Prosta glandins in severe congestive heart failure: relation to activation of renin-angiotensin system and hyponatremia[J]. N Engl Med, 1984;310:347-52
  • 6Antiplatelet Trialists'Collaboration. Collaborative overview of randomised trials of antiplatelet therapy:prevention of death,myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients[J]. BMJ, 1994;308:81-106
  • 7Fitzgerald GA, Oates JA, Hawinger J, et al. Endogenous biosynthesis of prostacycline and thromboxane and platelet function during chronic administration of aspirin in men[J]. J Clin invest, 1983;71:676-8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部